Scholars Central

Research articlePublished 16 Mar 2018

Treatment improvement of pulmonary epithelioid hemangioendothelioma: A case report

Authors: Yalei Lv, Xue Zhang, Wei Liu

Biomedical Research

Volume 29 · Issue 4 · Pages 640–643

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Pulmonary Epithelioid Hemangioendothelioma (PEH) is one rather rare low-grade malignant tumor. Owing to its relatively low incidence, standard treatments on PEH are relatively less. A 52 y old male PEH patient treated with endostatin had received outstanding clinical outcome, considering his brain metastases and pleural effusion were both negative effects upon prognosis. Patient’s pathological characteristics, iconographic characteristics would play an essential role on his response to clinical treatment and prognosis. So far, standard treatments upon PEH are still not available, and the inhibition of tumor growth can be achieved through inhibition of tumor angiogenesis and interrupting cellular nutritious supply.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBiomedical Research
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Yalei Lv”
  • BylineArticles whose byline prints “Xue Zhang”
  • BylineArticles whose byline prints “Wei Liu”